Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02841397 · ClinicalTrials.gov registry record
Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI
A clinical trial, sponsored by Masimo Corporation.
- Completed
- Registry status
- 50
- Enrollment target
NCT02841397 is a clinical trial that has completed, run by Masimo Corporation. The registered enrollment target is 50 participants.
The verdict
NCT02841397 has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The study goal is to establish the correlation of hemoglobin values determined by the noninvasive pulse oximetry-determined hemoglobin (SpHb) system with hemoglobin as measured by other validated devices. The study will also evaluation oxygen reserve index (ORI) to correlate with partial pressure of oxygen (PaO2), and to evaluate pleth variability index (PVI) with stroke volume variation (SVV) or pulse pressure variation (PPV) values.
Interventions
- DEVICE Masimo Pulse CO-Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2017-10-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02841397
The ClinicalTrials.gov registry entry for NCT02841397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Pulse CO-Oximeter is the first listed.
NCT02841397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02841397 about?
NCT02841397 is a clinical study titled "Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI". The study goal is to establish the correlation of hemoglobin values determined by the noninvasive pulse oximetry-determined hemoglobin (SpHb) system with hemoglobin as measured by other validated devices. The study will also evaluation oxygen reserve index (ORI) to correlate with partial pressure of...
What is the current status of trial NCT02841397?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-03-09. Estimated completion is 2017-10-11.
What interventions are being tested in trial NCT02841397?
The interventions under investigation include: Masimo Pulse CO-Oximeter (DEVICE).
Who is sponsoring clinical trial NCT02841397?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.